Executive Director, Worldwide Market Research - Immuno-Oncology
Praveen Advani has more than 17 years of experience leading global market research efforts for new products and in-line brands in the
Pharmaceutical Industry. Praveen is currently Executive Director, Worldwide Market Research - Immuno-Oncology at Bristol-Myers Squibb.
He was previously the Director & Team Leader for Womens Health, Insomnia and Pain Franchises in Global Market Research & Analytics at
Merck. In his 9 years at Merck, he successfully led global market research efforts for the launches of Diabetes (Januvia/Janumet) and
Glaucoma (Saflutan) drugs. Prior to Merck, Praveen was with Aventis Pharmaceuticals (now Sanofi-Aventis) for over 6 years and was
instrumental in leading global market research for the successful launch of Lantus.
Praveen holds a M.B.A. from Thunderbird, The American Graduate School of International Management and a Bachelors degree in Engineering
from the University of Pune,
Executive Director, Global Market Research Excellence
Merck & Co., Inc.
A strategic, solutions oriented business leader with over 20 years of success in delivering customer insights that drive business results, Lisa
has a passion for the healthcare industry and for the patients we serve. Lisa Courtade currently leads executional excellence and the
transformation of insights generation at Merck as the Executive Director of Global Market Research Excellence. In this role, she and her team
are responsible for driving business results and creating customer value by delivering value based innovation. Lisa was an early adopter of
engaging patients in marketing research and leveraging CPG methodologies in the pharma space which contributed to receipt of the ARF’s
David Ogilvy Award for creative use of insights in celebrate breakthrough moments when creative inspiration and research insights come
together to produce a spectacular advertising campaign.
Lisa lives her passion for shaping the future of the industry by serving on the Marketing Research Institute International Board (MRII) as Chair
of the Pharma Curriculum Committee and as an Advisory Board & Steering Committee member for the University of Georgia’s Masters in
Marketing Research program, where she also serves as an alumni mentor. Lisa is an active member of the Healthcare Businesswoman’s
Association (HBA) where she chaired Career Development and served as the first Global Research Director. In 2013 Lisa was awarded the
PMRG’s prestigious R.R. Fordyce Award for exemplary leadership, service and dedication to the healthcare industry and the healthcare market
Sr. Director Global Market Research
Sandipa Dublish heads the worldwide market research team at Alexion – a biopharmaceutical company focused on developing therapies for
life threatening ultra-rare diseases. In this role she has focused on developing innovative market research approaches, specifically designed
to get maximum insights in the ultra-rare disease landscape. Sandipa has utilized Big Data – alongside qualitative research to get thick
descriptions of physician and patient behavior. Sandipa is now busy expanding the Alexion market research team around the globe, as well as
building a New Products Commercial Assessment team at the US headquarters.
Sandipa has extensive experience in Global launch planning and life cycle assessment. She has launched three oncology drugs – Halaven,
Ixempra, and Sprycel. .
Sandipa holds a PhD. in Marketing from Florida International University, Miami.
Steve is President of Ipsos Health in North America, with responsibility for quantitative research and IUU-Health teams. He is a member of the
global healthcare and new product development boards.
Previously, Steve was Senior Vice President and General Manager at Campbell Alliance. He was also a founding member of the Corporate
Strategy Practice, in addition to his group leadership responsibilities. He is a dynamic leader and business builder with experience across Life
Sciences, Healthcare, Digital, Healthcare IT and IT Services.
Prior to Campbell, Steve was an instrumental partner on the leadership teams of the Omnicom/CDM strategy practice and at Leerink Swann,
the Healthcare Investment Bank. Previously, he built and led Smart Analyst, an early global pioneer of the Onshore/Offshore BPO/KPO analytics
and consulting model. He spent the first 10 years of his career in leading sales and marketing roles with Gideon Gartner's Giga Information
Group and through acquisition as a Regional Director at Forrester Research.
Steve has a BSc (Hons) in Information Systems Management from Bournemouth University, UK.
Deputy Director, Global/Oncology Market Research
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and
quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global
Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on
cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned
his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
US Specialty Care Lead – Business Analytics & Insights
Dr. Hale has been with Pfizer’s market analytics group for 10 years. She currently leads the market analytics group supporting the US in-line
brands for Pfizer’s Specialty Care Business Unit. In addition to this role, she also leads the Center of Excellence for HCPs, which is tasked with
identifying innovative, efficient research solutions for business issues and decisions relating to our physician customers. She has held several
other positions within Pfizer, including the Market Analytics Team Leader for Urology/Respiratory brands, as well as Global Market Analytics
Team Leader for New Product Development for a wide range of therapeutic areas.
Prior to joining Pfizer, Anne was a Marketing Professor at both McGill University in Montreal and the University of Victoria in Victoria, British
Columbia, Canada, where she taught such courses as Marketing Management, Marketing Research, Business Statistics, Advertising, and
Retail Management at both the undergraduate and graduate levels. In addition, she also served a term as Dean of the Undergraduate Program
at both McGill University and the University of Victoria, as well as teaching in the Executive Education Institutes of both universities.
Anne holds a Bachelor of Business Administration, Masters of Business Administration and a Doctorate in Marketing, specializing in
quantitative methodology, all from the University of Texas at Austin.
Executive Director, Forecasting, Analytics & Market Research
||Grace Samoil Reynolds
Head Market Insights
Grace is Head of Market Insights at Celgene. She was previously at Johnson & Johnson where she joined in 1997 in the Market Research
Department at Personal Products (consumer). She then progressed through roles in Market Research and Forecasting management in the
Pharmaceutical Sector, including responsibility for Women’s Health, Urology and Pain at Ortho McNeil. Most recently, she was responsible for
Market Research and Forecasting for the CNS and Pain Franchises in early Pharmaceutical Development. She also has experience in
Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at Schering Plough and Colgate Palmolive, primarily in a Market
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her
passion is driving innovation and future thinking.
Sr. Director, Business Development
Jocelyn Trokenheim is Sr. Director, Business Development, at Takeda Pharmaceuticals USA, Inc. In this role, Jocelyn is responsible for
assessments and valuations of licensing, merger and acquisition opportunities. Her efforts had contributed to Takeda’s acquisition of
Nycomed in 2010 and Takeda’s recent acquisition of URL Pharma in the US. The Nycomed acquisition was the largest acquisition ever
completed by Takeda and the second largest acquisition ever completed by a Japanese company. The acquisition of URL Pharma was the
first company acquisition in the US for Takeda since 2008.
Prior to assuming the Business Development role, Jocelyn was Sr. Director, Business Insights and Strategy, at Takeda Pharmaceuticals North
America, Inc. Jocelyn built and led a department of 28 professionals, with responsibilities spanning across all aspects of commercial
analytics including forecasting, marketing analytics, business development assessment, decision science, market research, commercial
reporting and data governance, for all of Takeda’s in-market products, pipeline compounds, as well as business development opportunities.
In addition to her expertise in commercial analytics, Jocelyn is an accomplished and passionate leader in developing in-house analytical
capabilities and building skilled teams to increase cross-functional collaborations and organizational efficiency.
Jocelyn started her career with ZS Associates, as one of the founding members of its market research practice while gaining extensive
experience in pharmaceutical sales and marketing analytics. Born and raised in Taiwan, Jocelyn moved to the United States after high school
without speaking a word of English, and subsequently earned a B.S. and an MSBA degree in Business Analysis from San Francisco State
University, and received an MSc degree in Management Science from Queen’s University in Kingston, Ontario, Canada.